The Company is a Taiwan-based company primarily engaged in the drug development business. The Company s products and services are mainly new drug development and sales, contract development and manufacturing services, testing services and other services.
The Company s cellular products are categorized into allogeneic mesenchymal stem cell drugs and autologous cell medical technology development cellular products. The Company is also engaged in the provision of aseptic filling services, Good Tissue Practice (GTP) laboratory setup and quality documentation counseling services, and laboratory information management systems. The Company sells its products and services primarily domestically.
History
The Company was established on June 12, 2019.The Company listed on Public Companies of Taiwan Stock Exchange on August 30, 2023.The Company listed on Emerging Stocks of Taiwan Stock Exchange on September 7, 2023.
Headquarters
6 F., No. 1490, Chunri Rd, Taoyuan Dist
Taoyuan City; Taoyuan City;
Contact Details: Purchase the Hexun Biosciences Co. Ltd. report to view the information.
Website: http://www.hexunbio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service